← All trials
NCT04693286
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 21, 2020
- Primary completion
- Dec 30, 2021
- Completion date
- Dec 30, 2021
- First posted
- Jan 5, 2021
- Last posted
- Oct 1, 2021
- Enrollment
- 330
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- International Center for Diarrheal Disease ResearchLead sponsor
- PATHCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
- International Center for Diarrheal Disease ResearchOverall official - principal investigator
- Bill and Melinda Gates FoundationCollaborator
- World Health OrganizationCollaborator
- PT Bio FarmaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.